Clinical Trial Update: A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes an ongoing Phase 1/2 study of nimotuzumab plus adebrelimab with chemotherapy in cisplatin-ineligible patients with head and ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Fudan University | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING